行情

ATRC

ATRC

AtriCure
NASDAQ

实时行情|Nasdaq Last Sale

25.90
+0.16
+0.63%
交易中 13:06 09/17 EDT
开盘
25.75
昨收
25.74
最高
26.12
最低
25.39
成交量
5.54万
成交额
--
52周最高
36.49
52周最低
22.57
市值
10.05亿
市盈率(TTM)
-42.9398
分时
5日
1月
3月
1年
5年

分析师评级

8位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

ATRC 新闻

  • 新iPad Pro谍照流出 配备与新iPhone类似的三摄系统
  • 新浪美股.2小时前
  • 投资者对莫迪经济学失望,印度出现大规模资本外流
  • 环球外汇网官网.2小时前
  • 基金经理对经济衰退的担忧升至10年来的最高水平
  • 环球外汇网官网.2小时前
  • 沙特产量恢复速度超预期,布油跌幅扩大至6%
  • 环球外汇网官网.2小时前

更多

所属板块

医疗设备、用品及经销
+0.47%
医疗设备和用品
+0.39%

热门股票

名称
价格
涨跌幅

ATRC 简况

AtriCure, Inc. is an atrial fibrillation (Afib) solutions company. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. It has various product lines for the ablation of cardiac tissue, including its Isolator Synergy Ablation System, for the treatment of persistent and longstanding persistent forms of Afib in patients undergoing certain open concomitant procedures. It has two primary product lines for cardiac tissue ablation, which include Radio Frequency Ablation Devices and cryoICE Cryoablation System, and a product line for left atrial appendage exclusion. The Company also sells Lumitip dissectors and the Estech line of reusable cardiac surgery (valve) instruments. Its cryoICE cryosurgery product line offers various cryoablation devices. Its AtriClip Left Atrial Appendage Exclusion System is designed to occlude the heart's left atrial appendage (LAA).
展开

Webull提供AtriCure Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。